Greetings from MyCancerHaven!

We wanted to update you on our recent activities.

Here are the latest posts last week:

‍Blogs :

Utilization of Targeted Agents in Patients with Relapsed/Refractory Follicular Lymphoma

Dr. Gordon discusses optimizing Liso-Cel use in relapsed/refractory MCL.

Using CAR T-cell therapy for patients with relapsed/refractory follicular lymphoma.

Investigating CAR T-cell therapy for aggressive lymphomas like DLBCL and CLL/SLL.

Community oncologists express confidence in using bispecifics for B-cell lymphoma.
‍
‍Also at MCH the News and Tweets never stop flowing!

Join Us at www.mycancerhaven.org

‍The Team @ MCH

Follow us on Facebook, Twitter (@My_Cancer_Haven), Instagram, YouTube, LinkedIn and TikTok

Note: Please do not reply to this e-mail as it is sent from an account that is not monitored. You can contact us by e-mail at contact@mycancerhaven.org.